Linearis Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Linearis Ventures/Activity

Linearis Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Team Change

Added Karimah Es Sabar, former Quark Venture CEO, as strategic life sciences and venture capital advisor.

Karimah Es Sabar joined as strategic advisor

Linearis Ventures

linearis.comSEP 9, 2026

ca.finance.yahoo.com

SEP 9, 2026

Investment

Co-led Scopia Surgical's oversubscribed C$2.65M pre-seed round for AI-powered robotic surgery navigation.

Scopia Surgical

Scopia Surgical Linearis Ventures

prnewswire.comSEP 1, 2026

SEP 1, 2026

Milestone

Portfolio company Noetik signed a five-year, $50M USD licensing partnership with GSK for its OCTO-VC virtual cell foundation models in cancer R&D.

Noetik

Noetik Linearis Ventures

linearis.comJAN 8, 2026

JAN 8, 2026

Investment

Joined Zilia's bridge financing round as a new investor, supporting its non-invasive ocular biomarker platform ahead of a planned institutional raise.

Zilia

Zilia Linearis Ventures

linearis.comMAY 7, 2025

MAY 7, 2025

Investment

Made a strategic investment in Feldan Therapeutics to accelerate its intracellular drug-delivery pipeline, including lead candidate FLD-103.

Feldan Therapeutics

Feldan Therapeutics Linearis Ventures

feldan.comFEB 18, 2025

FEB 18, 2025